OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
September 02, 2012
Import controls and risk strategies aim to promote quality and spur new drug development.
August 02, 2012
No matter the upside or downside to the Affordable Care Act, there's work to be done.
July 31, 2012
Prominent scientists and political leaders at the International AIDS Conference in Washington, D.C., in late July were optimistic for the first time about bringing an end to the global AIDS pandemic.
July 02, 2012
A Q&A with FDA Deputy Commissioner Deborah Autor.